Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review

Yu Si Yao1, Tu Di Li1, Zhi Huan Zeng2

  • 1Department of Cardiovascular Diseases, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510080, People's Republic of China.

Insights

High cholesterol (hyperlipidemia) directly harms heart function and increases heart failure risk. Lowering lipids can reverse cardiac dysfunction, offering protective strategies for patients.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Molecular Biology

Background:

  • Hyperlipidemia is a significant risk factor for cardiovascular disease.
  • It is linked to increased non-ischemic heart failure and cardiac dysfunction.
  • Direct cardiac effects of hyperlipidemia, beyond atherosclerosis, are not fully understood.

Purpose of the Study:

  • To review mechanisms of hyperlipidemia's direct impact on cardiac function.
  • To explore the relationship between serum lipids and heart failure.
  • To summarize the cardioprotective effects of lipid-lowering therapies.

Main Methods:

  • Review of recent experimental and clinical studies.
  • Analysis of mechanisms involving cardiac lipid accumulation, oxidative stress, inflammation, and mitochondrial dysfunction.
  • Synthesis of data on lipid-lowering drug efficacy.

Main Results:

  • Hyperlipidemia directly impairs systolic function and cardiac electrophysiology.
  • Cardiac lipid accumulation contributes to oxidative stress and inflammation.
  • Lipid reduction shows potential for reversing heart dysfunction.

Conclusions:

  • Understanding direct cardiac effects of hyperlipidemia is crucial.
  • Lipid management is key for preventing and treating heart failure.
  • Targeting lipid pathways offers promising cardioprotective strategies for hyperlipidemic patients.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
304
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
689
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
286
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
277